Teaching GuideTerm
Faculty of Science
  Home | galego | castellano | english | A A |  
Mestrado Universitario en Biotecnoloxía Avanzada
  Specific novel drug design (Pharmacology and Pharmacogenomics)
   Sources of information

Gielen M., Tiekink R.T , Metallotherapeutic drugs & Metal-based, J.Wiley & Sons, Cornwall 2005,

Sessler, J.L., Doctrow, S.R, McMurry, T.J.,Lippard, S.J. , MedicinalInorganic Chemistry, ACS, Washington, 2005, Lukehart,

M., Scott, R.A. , Nanomaterials: Inorganicand Bioinorganic, John Wiley & Sons, Chichester, 2008

E. I. Pertsov , Nanomaterials: New ResearchDevelopments, Nova. New York. 2008.

Martin M. Zdanowicz, Concepts inPharmacogenomics , ASHP; 1 edition (January 1, 2010) ,

Federico Innocenti , Genomics and Pharmacogenomicsin Anticancer Drug Development and Clinical Response (Cancer Drug Discovery andDevelopment) , Humana Press; 1 edition (October 23, 2008) ,

Bernd Meibohm , Pharmacokinetics andPharmacodynamics of Biotech Drugs: Principles and Case Studies in DrugDevelopment , Wiley-VCH; 1 edition (January 2, 2007)

Jones, C. J., Thomback, J. R., Medicinal Applications of Coordination Chemistry. Royal Society of Chemistry, Cambridge, 2007.

Editor: Luís Alvarez Vallina, Anticuerpos monoclonales. Realidades y perspectivas. Editorial complutense. 2004.

Steinitz, Michael (Ed.). Human Monoclonal Antibodies, Humana Press, 2014.

Crichton, R. R. Biological Inorganic chemistry: a new introduction to molecular structure and function, Elsevier Academic, 2012.

Aguilar, ZP. Nanomaterials for medical applications, Oxford: Elsevier, 2013.

Dobrovolskaia, M.A., McNeil S.E., Handbook of immunological properties of engineered nanomaterials , World scientist, 2016

Wood, C.R., Antibody Drug Discovery, World scientist, 2011

Sabater Tobella, J., Sabater Sales G., Medicina personalizada posgenómica: conceptos prácticos para clínicos, Elsevier, 2010


Universidade da Coruña - Rúa Maestranza 9, 15001 A Coruña - Tel. +34 981 16 70 00  Soporte Guías Docentes